There has been a growing interest in cell therapy over the last decade where research and innovations delved deeper into discovering the true potential of cell therapy. A prominent advantage of cell therapy is its ability to treat patients with life threatening illness such as cancer. Led by recent launches of cell therapy products such as the Bristol Myers Squibb's Breyanzi and Novartis' large-scale manufacturing of Kymriah, the industry has seen accelerated growth over the past few years. The field of cell therapy manufacturing presents high-value opportunities for Singapore and its workforce. This professional certificate aims to provide a strong foundation for learners to develop their knowledge and expertise in the exciting field of cell therapy and gain competencies in the following areas. - Process of CAR-T cell treatment and its key steps - Regulation of CAR-T cell treatment and implications on the practice of cell therapy - Quality control and assurance aspects of manufacturing and application of cell-based therapeutics to patients - Manufacturing of CAR-T cell for cell therapy treatments - Considerations involved in cell therapy clinical research